Symposium NGS 2016 [1]
Date: Tuesday, October 25, 2016 (All day)
Date:
Tuesday, October 25, 2016 (All day)
Event type:
symposium
Spoken language(s):
Dutch
English
Audience:
all
Description
Introduction of Next-Generation-Sequencing technology in (hemato-)oncology in the Belgian health care system.
The use of Next generation sequencing technology in routine analyses carried out as part of our healthcare system represents a major step forward. In Belgium, the introduction of this technology in (haemato-)oncology is being developed in a 5-year national pilot project coordinated by the PSI Cancer Centre, a project launched in January 2016.
Program
09.30h - 10.15h : Welcome
10.30h — 12.30h : Introduction of NGS in (haemato)oncology in Belgium
Introductie NL — M. Van Den Bulcke, WIV-ISP [2]- Commission Personalized Medicine (EN) — M. Van Den Bulcke, WIV-ISP [3]
- Platform CRM — TMC: a link procedure for companion reimbursement (EN) — A. Waeytens, RIZIV-INAMI [4]
- Guidelines ‘NGS in (hemato-)oncology’ NGS genepanel testing (EN) — A. Hébrant, WIV-ISP [5]
- Benchmarking trial and EQA NGS in (hemato-)oncology (EN) — V. Ghislain, WIV-ISP [6]
- Patient participation: Focus group (EN) - K. Moens, WIV-ISP [7]
- Healthdata Datamanagement for NGS (EN) - J. Van Bussel, WIV-ISP [8]
- Accreditation of NGS within ISO 15189 (EN) - E. Van Rossen, SPF Economie [9]
12.30h — 13.30h : Lunch
13.30h — 16.00h : “Genomics in oncology and hematology: opportunities & challenges
- “Precision”: Bringing innovation to the patient (EN) — J. De Grève, Vrije Universiteit Brussel, Bruxelles, Belgique [10]
- JARC: Joint Action Rare cancers (EN) — A. Trama, Instituto Nationale di Tumori, Milan, Italie [11]
- Impact on current and future cancer immunotherapies (EN) — K. Vermaelen, UGent, Gand, Belgique [12]
- Liquid biopsies (EN) — S. Tejpar, KU Leuven, Louvain, Belgique [13]
- NGS for oncogenetics (EN) - M. Abramowicz, Université Libre de Bruxelles, Bruxelles, Belgique [14]
- Comprehensive Genomic Profiling with FMI — bringing value to patients (EN) — V. Natarajan, Foundation Medicine, Europe [15]
16.00h — 17.30h : Reception
Related Projects
- Commission de Médecine Personnalisée (ComPerMed) [16]
- ComPerMed — Next-Generation Sequencing in hemato(-oncology) [17]
- Focus Groups: Information Needs and Attitudes of Cancer Patients to NGS Testing [18] (FR)
This event contributes to Sciensano's activities in the field of:
Quality of healthcare
Cancer
Address
Bd du Jardin Botanique 44
1000 Brussels
BelgiumPrice
Free
Contact
Aline Hebrant